Transcranial Magnetic Stimulation in Children With Attention Deficit Hyperactivity Disorder (ADHD). A Safety Study

Attention Deficit Hyperactivity Disorder Clinical Trial

Official title: Therapy With rTMS in Children With Attention Deficit and Hyperactivity Disorder. Phase 1 Study.

Status Recruiting

Clinical Trial Summary

Low frequency repetitive Transcranial Magnetic Stimulation(rTMS) is a safe and tolerable procedure in children with Attention Deficit Hyperactivity Disorder(ADHD); it also could be a complement to the treatment of patients with poor symptomatic control to conventional treatment.

Clinical Trial Description

Attention Deficit Hyperactivity Disorder is a common disorder in the infancy; the majority of ADHD have good clinical response to amphetamines alone or in association with antiepileptic drugs. It is described that some patients(10-30%) with ADHD do not respond to conventional pharmacological and psycho- pedagogical treatment; in those patients non invasive brain stimulation methods could be a supplementary option for symptomatic control. There are not many published papers describing the effects of rTMS in persons younger than 18 years; so the first step to extent its use in pediatric population should be to obtain evidences about its tolerance and safety. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit Hyperactivity Disorder
• Hyperkinesis

• NCT number: NCT01052064
• Study type: Interventional
• Source: International Center for Neurological Restoration, Cuba
• Contact: Lázaro Gómez, MD
• Phone: 53 7 2715353
• Email: lazarog@neuro.ciren.cu
• Status: Recruiting
• Phase: Phase 1
• Start date: April 2009
• Completion date: April 2010